Question: Patent infringement typically is caused by using or selling a patented invention without permission from the patent holder. The scope of the patented invention or the extent of protection is defined in the claims of the granted patent. There is safe harbor in many jurisdictions to use a patented invention for research. This safe harbor does not exist in the US unless the research is done for purely philosophical purposes, or in order to gather data in order to prepare an application for regulatory approval of a drug. In general, patent infringement cases are handled under civil law (e.g., in the United States) but several jurisdictions incorporate infringement in criminal law also (for example, Argentina, China, France, Japan, Russia, South Korea).
Is there an answer to this question: Where does the safe harbor to use a patented invention for research generally not exist?

Answer: in the US

Question: Melting of floating ice shelves (ice that originated on the land) does not in itself contribute much to sea-level rise (since the ice displaces only its own mass of water). However it is the outflow of the ice from the land to form the ice shelf which causes a rise in global sea level. This effect is offset by snow falling back onto the continent. Recent decades have witnessed several dramatic collapses of large ice shelves around the coast of Antarctica, especially along the Antarctic Peninsula. Concerns have been raised that disruption of ice shelves may result in increased glacial outflow from the continental ice mass.
Is there an answer to this question: What could the displacement of ice cause?

Answer: glacial outflow

Question: A Federal Trade Commission report issued in 1958 attempted to quantify the effect of antibiotic development on American public health. The report found that over the period 1946-1955, there was a 42% drop in the incidence of diseases for which antibiotics were effective and only a 20% drop in those for which antibiotics were not effective. The report concluded that "it appears that the use of antibiotics, early diagnosis, and other factors have limited the epidemic spread and thus the number of these diseases which have occurred". The study further examined mortality rates for eight common diseases for which antibiotics offered effective therapy (syphilis, tuberculosis, dysentery, scarlet fever, whooping cough, meningococcal infections, and pneumonia), and found a 56% decline over the same period. Notable among these was a 75% decline in deaths due to tuberculosis.
Is there an answer to this question: What was responsible for the decline in spreading commissions?

Answer: unanswerable

Question: The first high-brightness blue LED was demonstrated by Shuji Nakamura of Nichia Corporation in 1994 and was based on InGaN. In parallel, Isamu Akasaki and Hiroshi Amano in Nagoya were working on developing the important GaN nucleation on sapphire substrates and the demonstration of p-type doping of GaN. Nakamura, Akasaki and Amano were awarded the 2014 Nobel prize in physics for their work. In 1995, Alberto Barbieri at the Cardiff University Laboratory (GB) investigated the efficiency and reliability of high-brightness LEDs and demonstrated a "transparent contact" LED using indium tin oxide (ITO) on (AlGaInP/GaAs).
Is there an answer to this question: What did Nakamura, Akasaki, and Amano receive for their work?

Answer:
2014 Nobel prize in physics